RedHill Biopharma Reports Further Analysis of Phase 2/3 Data I...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TEL AVIV, Israel and RALEIGH, N.C., Oct. 4, 2021 /PRNewswire-AsiaNet/ -- 62% statistically significant reduction in mortality shown for moderately severe COVID-19 patients group treated with opaganib vs. the placebo-controlled arm (7 deaths in the 117-patient opaganib arm vs. 21 deaths in the 134-patient placebo arm; n...
Authors: LATEST ASIANET NEWS RELEASES